Financial Ratios | Vivimed Labs Ltd. | R Wadiwala Securities Pvt Ltd

NSE : BSE : ISIN CODE : Industry : House :

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-39.62-8.16-8.67-13.166.95
   CEPS(Rs)-26.55-5.95-1.98-5.0915.04
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.1739.3547.4756.8570.35
   Tax Rate(%)0.64-4.35-2.900.3313.14
Margin Ratios
   Core EBITDA Margin(%)-99.94-3.303.700.6212.84
   EBIT Margin(%)-157.36-10.47-1.60-4.5810.35
   Pre Tax Margin(%)-176.72-27.32-8.11-10.345.02
   PAT Margin (%)-175.59-28.51-8.34-10.314.36
   Cash Profit Margin (%)-117.65-20.80-1.90-3.989.44
Performance Ratios
   ROA(%)-29.15-5.29-4.13-4.832.44
   ROE(%)-200.50-18.80-16.62-20.757.95
   ROCE(%)-55.28-3.54-1.12-2.697.03
   Asset Turnover(x)0.170.190.490.470.56
   Sales/Fixed Asset(x)0.230.300.850.871.15
   Working Capital/Sales(x)-2.031.774.595.163.85
Efficiency Ratios
   Fixed Capital/Sales(x)4.353.301.181.150.87
   Receivable days160.14149.8775.54104.3187.64
   Inventory Days312.65381.82160.49183.67153.18
   Payable days74.8290.54134.23205.53174.76
Valuation Parameters
   PER(x)0.000.000.000.003.37
   PCE(x)-0.25-2.43-8.02-1.431.56
   Price/Book(x)38.890.370.330.130.33
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.301.990.521.211.05
   EV/Core EBITDA(x)-2.31-71.9110.8169.076.79
   EV/EBIT(x)-1.46-18.98-32.67-26.3710.12
   EV/CE(x)0.440.370.350.580.59
   M Cap / Sales0.300.500.150.060.15
Growth Ratio
   Net Sales Growth(%)-21.15-72.46-18.64-19.4910.92
   Core EBITDA Growth(%)-2736.91-115.72125.44-90.88-9.62
   EBIT Growth(%)-1085.28-80.0971.53-135.60-19.01
   PAT Growth(%)-385.645.8934.12-290.21-24.61
   EPS Growth(%)-385.635.8934.12-289.32-26.40
Financial Stability Ratios
   Total Debt/Equity(x)266.221.100.831.181.05
   Current Ratio(x)0.781.361.551.271.38
   Quick Ratio(x)0.600.710.800.610.75
   Interest Cover(x)-8.13-0.62-0.25-0.791.94
   Total Debt/Mcap(x)6.853.002.4815.664.94